259 related articles for article (PubMed ID: 8418241)
1. A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer.
Gilbert L; Elwood LJ; Merino M; Masood S; Barnes R; Steinberg SM; Lazarous DF; Pierce L; d'Angelo T; Moscow JA
J Clin Oncol; 1993 Jan; 11(1):49-58. PubMed ID: 8418241
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
Huang J; Bay BH; Tan PH
Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
4. Relation of glutathione S-transferase alpha and mu isoforms to response to therapy in human breast cancer.
Alpert LC; Schecter RL; Berry DA; Melnychuk D; Peters WP; Caruso JA; Townsend AJ; Batist G
Clin Cancer Res; 1997 May; 3(5):661-7. PubMed ID: 9815734
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
Silvestrini R; Veneroni S; Benini E; Daidone MG; Luisi A; Leutner M; Maucione A; Kenda R; Zucali R; Veronesi U
J Natl Cancer Inst; 1997 May; 89(9):639-45. PubMed ID: 9150188
[TBL] [Abstract][Full Text] [Related]
6. Glutathione S-transferase activity in human breast tumors.
Colovai AI; Stoica A; Cinca SA; Marin M; Gruia M; Condrea I; Petrescu D; Dutu R
Neoplasma; 1992; 39(4):249-54. PubMed ID: 1436238
[TBL] [Abstract][Full Text] [Related]
7. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
8. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases.
Peters WH; Roelofs HM; van Putten WL; Jansen JB; Klijn JG; Foekens JA
Br J Cancer; 1993 Jul; 68(1):86-92. PubMed ID: 8318426
[TBL] [Abstract][Full Text] [Related]
9. Studies on the relationship between estrogen receptor content, glutathione S-transferase pi expression, and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and drug resistance in human breast cancer cells.
Hoivik D; Wilson C; Wang W; Willett K; Barhoumi R; Burghardt R; Safe S
Arch Biochem Biophys; 1997 Dec; 348(1):174-82. PubMed ID: 9390189
[TBL] [Abstract][Full Text] [Related]
10. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of glutathione S-transferase pi expression and subcellular localization in human gliomas.
Ali-Osman F; Brunner JM; Kutluk TM; Hess K
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2253-61. PubMed ID: 9815622
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort.
Levesque MA; Yu H; Clark GM; Diamandis EP
J Clin Oncol; 1998 Aug; 16(8):2641-50. PubMed ID: 9704714
[TBL] [Abstract][Full Text] [Related]
14. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
16. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.
Soubeyran I; Quénel N; Coindre JM; Bonichon F; Durand M; Wafflart J; Mauriac L
Br J Cancer; 1996 Oct; 74(7):1120-5. PubMed ID: 8855985
[TBL] [Abstract][Full Text] [Related]
17. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase Pi expression in invasive breast cancer and its relation with the clinical outcome.
Franco RL; Schenka NG; Schenka AA; Rezende LF; Gurgel MS
J BUON; 2012; 17(2):259-64. PubMed ID: 22740203
[TBL] [Abstract][Full Text] [Related]
19. Progesterone and estrogen receptors as prognostic variables in breast cancer.
Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
[TBL] [Abstract][Full Text] [Related]
20. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]